News in hepatitis C: Report from the 39th annual meeting of the European Association for the Study of the Liver.
Zeuzem
Stefan
S
Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Endocrinology, Saarland University Hospital, Homburg/Saar, Germany. zeuzem@uniklinik-saarland.de
D000998:Antiviral Agents / Q000627:therapeutic use; D005060:Europe; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011092:Polyethylene Glycols; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D012958:Societies, Scientific
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b